Thomas Shrader
Stock Analyst at BTIG
(0.96)
# 3,713
Out of 4,876 analysts
47
Total ratings
34.15%
Success rate
-10.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALDX Aldeyra Therapeutics | Maintains: Buy | $11 → $9 | $3.79 | +137.47% | 1 | Apr 7, 2025 | |
| OVID Ovid Therapeutics | Maintains: Buy | $5 → $4 | $0.30 | +1,224.50% | 3 | Mar 24, 2025 | |
| PCVX Vaxcyte | Reiterates: Buy | $160 | $32.58 | +391.10% | 4 | Feb 24, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Buy | $41 | $13.33 | +207.58% | 1 | Jan 28, 2025 | |
| ALEC Alector | Maintains: Buy | $16 → $5 | $1.48 | +237.84% | 2 | Nov 26, 2024 | |
| ATHA Athira Pharma | Downgrades: Neutral | n/a | $0.30 | - | 3 | Sep 4, 2024 | |
| ACIU AC Immune | Initiates: Buy | $8 | $2.02 | +296.04% | 1 | May 31, 2024 | |
| PMN ProMIS Neurosciences | Initiates: Buy | $8 | $0.48 | +1,565.97% | 1 | Oct 3, 2023 | |
| DTIL Precision BioSciences | Maintains: Buy | $180 → $60 | $4.30 | +1,295.35% | 1 | Jul 28, 2023 | |
| BHVN Biohaven | Reiterates: Buy | $24 | $14.09 | +70.33% | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $7 | $2.41 | +190.46% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.85 | +156.41% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $13 | $0.38 | +3,285.42% | 3 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $31 | $93.82 | -66.96% | 3 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $1.97 | +407.61% | 2 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $1.12 | +1,864.29% | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $14 | $5.33 | +162.66% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $1.25 | +3,980.00% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.93 | +729.02% | 1 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.96 | - | 1 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.10 | - | 2 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $58 | $9.86 | +488.24% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.49 | +101.34% | 3 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $397 → $346 | $126.08 | +174.43% | 3 | Feb 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.45 | - | 1 | Jun 30, 2017 |
Aldeyra Therapeutics
Apr 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $3.79
Upside: +137.47%
Ovid Therapeutics
Mar 24, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.30
Upside: +1,224.50%
Vaxcyte
Feb 24, 2025
Reiterates: Buy
Price Target: $160
Current: $32.58
Upside: +391.10%
Arcturus Therapeutics Holdings
Jan 28, 2025
Initiates: Buy
Price Target: $41
Current: $13.33
Upside: +207.58%
Alector
Nov 26, 2024
Maintains: Buy
Price Target: $16 → $5
Current: $1.48
Upside: +237.84%
Athira Pharma
Sep 4, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.30
Upside: -
AC Immune
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $2.02
Upside: +296.04%
ProMIS Neurosciences
Oct 3, 2023
Initiates: Buy
Price Target: $8
Current: $0.48
Upside: +1,565.97%
Precision BioSciences
Jul 28, 2023
Maintains: Buy
Price Target: $180 → $60
Current: $4.30
Upside: +1,295.35%
Biohaven
Jun 6, 2023
Reiterates: Buy
Price Target: $24
Current: $14.09
Upside: +70.33%
May 25, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $2.41
Upside: +190.46%
May 18, 2023
Initiates: Buy
Price Target: $15
Current: $5.85
Upside: +156.41%
Mar 28, 2023
Maintains: Buy
Price Target: $68 → $13
Current: $0.38
Upside: +3,285.42%
Mar 20, 2023
Maintains: Buy
Price Target: $26 → $31
Current: $93.82
Upside: -66.96%
Nov 14, 2022
Maintains: Buy
Price Target: $30 → $10
Current: $1.97
Upside: +407.61%
Oct 5, 2022
Maintains: Buy
Price Target: $15 → $22
Current: $1.12
Upside: +1,864.29%
May 24, 2022
Maintains: Buy
Price Target: $31 → $14
Current: $5.33
Upside: +162.66%
Apr 20, 2021
Initiates: Buy
Price Target: $51
Current: $1.25
Upside: +3,980.00%
Mar 8, 2021
Initiates: Buy
Price Target: $16
Current: $1.93
Upside: +729.02%
Feb 3, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.96
Upside: -
Oct 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $14.10
Upside: -
Sep 15, 2020
Maintains: Buy
Price Target: $51 → $58
Current: $9.86
Upside: +488.24%
Apr 3, 2020
Maintains: Buy
Price Target: $4 → $3
Current: $1.49
Upside: +101.34%
Feb 21, 2019
Downgrades: Hold
Price Target: $397 → $346
Current: $126.08
Upside: +174.43%
Jun 30, 2017
Downgrades: Hold
Price Target: n/a
Current: $0.45
Upside: -